Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer

MFN2型 内质网 线粒体 癌细胞 细胞生物学 生物 化学 癌症研究 线粒体融合 癌症 生物化学 线粒体DNA 遗传学 基因
作者
Lara Milane,Saket Dolare,Guosheng Ren,Mansoor M. Amiji
出处
期刊:Journal of Controlled Release [Elsevier]
卷期号:363: 435-451
标识
DOI:10.1016/j.jconrel.2023.09.023
摘要

It is time for the story of mitochondria and intracellular communication in multidrug resistant cancer to be rewritten. Herein we characterize the extent and cellular advantages of mitochondrial network fusion in multidrug resistant (MDR) breast cancer and have designed a novel nanomedicine that disrupts mitochondrial network fusion and systematically manipulates organelle fusion and function. Combination Organelle Mitochondrial Endoplasmic reticulum Therapy (COMET) is an innovative translational nanomedicine for treating MDR triple negative breast cancer (TNBC) that has superior safety and equivalent efficacy to the current standard of care (paclitaxel). Our study has demonstrated that the increased mitochondrial networks in MDR TNBC contribute to apoptotic resistance and network fusion is mediated by mitofusin2 (MFN2) on the outer mitochondrial membrane. COMET consists of three components; Mitochondrial Network Disrupting (MiND) nanoparticles (NPs) that are loaded with an anti-MFN2 peptide, tunicamycin, and Bam7. The therapeutic rationale of COMET is to reduce the apoptotic threshold in MDR cells with MiND NPs, followed by inducing the endoplasmic reticulum mediated unfolded protein response (UPR) by stressing MDR cells with tunicamycin, and finally, directly inducing mitochondrial apoptosis with Bam7 which is a specific bcl-2 Bax activator. MiND NPs are PEGylated liposomes with the 21 amino acid (2577.98 MW) anti-MFN2 peptide compartmentalized in the aqueous core. Hypoxia (0.5% oxygen) was used to create MDR derivatives of MDA-MB-231 cells and BT-549 cells. Mitochondrial networks were quantified using 3D analysis of 60× live cell images acquired with a Keyence BZ-X710 microscope and MiND NPs effectively fragmented mitochondrial networks in drug sensitive and MDR TNBC cells. The IC50 values, combination index, and dose reduction index derived from dose response studies demonstrate that MiND NPs decrease the apoptotic threshold of both drug sensitive and MDR TNBC cells and COMET is a synergistic drug combination. Complex V (ATP synthase) extracted from bovine cardiac mitochondria was used to assess the effect of MiND NPs on OXPHOS; both MiND NPs and anti-MFN2 peptide solution significantly decrease the activity of mitochondrial complex V and decrease the capacity of OXPHOS. A BacMam viral vector based fluorescent biosensor was used to quantify the unfolded protein response (UPR) at the level of the endoplasmic reticulum and tunicamycin specifically induces the UPR in drug sensitive and MDR TNBC cells. A caspase 3 colorimetric assay demonstrated that the synergistic triple drug combination of COMET increases the ability of Bam7 to specifically induce apoptosis. Dose limiting toxicity and off target effects are a significant challenge for current chemotherapy regimens including paclitaxel. COMET has significantly lower cytotoxicity than paclitaxel in human embryonic kidney epithelial cells and has the potential to fulfill the clinical need for safer cancer therapeutics. COMET is a promising early stage translational nanomedicine for treating MDR TNBC. Manipulating intracellular communication and organelle fusion is a novel approach to treating MDR cancer. The data from this study has rewritten the story of mitochondria, organelle fusion, and intracellular communication and by targeting this intersection, COMET is an exciting new chapter in cancer therapeutics that could transform the clinical outcome of MDR TNBC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我们完成签到,获得积分10
刚刚
4秒前
仰山雪发布了新的文献求助10
5秒前
5秒前
管夜白完成签到 ,获得积分10
6秒前
陈1992完成签到 ,获得积分10
7秒前
8秒前
Rhome发布了新的文献求助30
10秒前
wangxin完成签到,获得积分10
12秒前
发光小组发布了新的文献求助10
18秒前
紧张的背包完成签到,获得积分10
21秒前
今后应助莫羽倾尘采纳,获得10
26秒前
Rhome完成签到,获得积分10
27秒前
123abc发布了新的文献求助10
28秒前
撒旦撒大苏打的完成签到,获得积分10
29秒前
运气贼好的熊猫完成签到 ,获得积分10
30秒前
31秒前
kmario完成签到,获得积分10
31秒前
赘婿应助科研通管家采纳,获得10
32秒前
深情安青应助科研通管家采纳,获得30
32秒前
benben应助科研通管家采纳,获得10
32秒前
32秒前
CodeCraft应助科研通管家采纳,获得10
32秒前
ding应助科研通管家采纳,获得20
32秒前
英俊的铭应助科研通管家采纳,获得10
32秒前
共享精神应助科研通管家采纳,获得10
32秒前
32秒前
乐乐应助科研通管家采纳,获得10
32秒前
saveMA完成签到,获得积分10
33秒前
酷波er应助add采纳,获得10
35秒前
真实的火车完成签到,获得积分10
38秒前
小甜面酱发布了新的文献求助10
39秒前
yzz应助LIN采纳,获得10
43秒前
44秒前
顾矜应助mbf采纳,获得10
44秒前
45秒前
0000给0000的求助进行了留言
45秒前
fddd完成签到 ,获得积分10
46秒前
受伤山槐发布了新的文献求助20
49秒前
50秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
A radiographic standard of reference for the growing knee 400
Glossary of Geology 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2474792
求助须知:如何正确求助?哪些是违规求助? 2139786
关于积分的说明 5452976
捐赠科研通 1863347
什么是DOI,文献DOI怎么找? 926407
版权声明 562840
科研通“疑难数据库(出版商)”最低求助积分说明 495557